- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
David Hung will become Axovant's CEO after completing the $14 billion sale of Medivation to Pfizer.
ChemoCentryx, Jazz Pharmaceuticals, Ionis Pharmaceuticals and Zogenix were among the biotech stock movers in premarket trading Friday.
Jim Cramer looks for domestic stocks he thinks will benefit from lower taxes and deregulation in the Trump era.